Of note, degradation of PML/RARalpha oncoprotein by arsenic trioxide enables acute promyelocytic leukemia (APL) a curable leukemia, because arsenic trioxide can eradicate APL leukemic stem cells by degradation of the oncoprotein (46). This evidence concerns the gene RARA and leukemia.